Medical/Pharmaceuticals

Advanced Aesthetic Technologies, Inc. is pleased to announce the approval of Algeness® VL agarose facial injection filler for marketing in China

AAT announces additional significant updates RADNOR, Pa., Jan. 29, 2025 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. ("AAT") announced today that their partner inChina has obtained approval to market their unique dermal filler Algeness® VL agarose facial injection filler, a 2.5% agarose...

2025-01-29 14:00 4422

Spectra Medical, XL Precision Technologies Announce Rebrand as Elevaris Medical Devices

Legacy of Trust and Expertise Ushers in New Era of Precision Medical Device Development and Manufacturing Capabilities BOSTON, Jan. 28, 2025 /PRNewswire/ -- Spectra Medical Devices (Spectra) and XL Precision Technologies (XLPT) announced today their newly combined brand presence as Elevaris Medi...

2025-01-28 23:15 5438

Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins

GOTHENBURG, Sweden, Jan. 28, 2025 /PRNewswire/ -- "In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions", says Mattias Perjos, CEO of Getinge. Grow...

2025-01-28 22:39 4177

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

The cutting-edge OncoPortal™ Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers BOSTON, MA and ROLLE, Switzerland, Jan. 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-dr...

2025-01-28 22:07 4201

Corti Launches Specialized Healthcare AI Infrastructure, Challenging Industry Misuse of General-Purpose Models

New purpose-built models, inspired by medical residency, tackle rising distractions and "pilot paralysis" from healthcare's increasing reliance on general-purpose AI NEW YORK, Jan. 28, 2025 /PRNewswire/ -- A new report from Corti and YouGov has revealed that a third of U.S. healthcare profession...

2025-01-28 14:00 3804

Telix Completes Acquisition of RLS (USA) Inc.

MELBOURNE, Australia and INDIANAPOLIS, Jan. 28, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition of RLS (USA) Inc. (RLS; RLS Radiopharmacies), America's only Joint Commission-accredited radiopharmacy n...

2025-01-28 05:40 8641

ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

TOKYO, Jan. 28, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of its new cell analysis platform, VisionCyte™. The announcement coincide...

2025-01-28 00:00 4651

Advanced Instruments Releases the OsmoPRO® MAX Automated Osmometer to Enhance Clinical Lab Productivity

The OsmoPRO® MAX Automated Osmometer delivers the automation and data management capabilities required by modern clinical labs. NORWOOD, Mass., Jan. 27, 2025 /PRNewswire/ -- Advanced Instruments, the leading supplier in osmolality testing, announces the newest update to its clinical line of free...

2025-01-27 22:28 4441

Seeking Investors: First-in-Class Immunotherapeutics for Cancer

ATLANTA, Jan. 27, 2025 /PRNewswire/ -- Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug is mutation-agnostic, and the company observes no toxicity-limiting dosages. In ...

2025-01-27 19:58 4466

Arab Health 2025|Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

DUBAI, UAE, Jan. 27, 2025 /PRNewswire/ -- On the eve of the Arab Health Exhibition, Yuwell Medical held its 2025 Global Core Partner Conference in Dubai , and announced astrategic investment and partnership with Inogen, a leading U.S. company in respiratory health, highlighting our joint commitmen...

2025-01-27 11:25 5688

CARiNG Pharmacy Celebrates Consecutive Gold Triumph at the 2024 Putra Aria Brand Awards

KUALA LUMPUR, Malaysia, Jan. 27, 2025 /PRNewswire/ -- CARiNG Pharmacy is thrilled to announce its back-to-back victory in securing the Gold award in the retail category at the 2024 Putra Aria Brand Awards. This recognition highlights the brand's unwavering commitment to excellence in the retail ...

2025-01-27 08:33 4537

Alpro Pharmacy and OMRON Healthcare Unite to Combat Fake BP Monitors

Free Blood Pressure Monitor Accuracy Check Nationwide KUALA LUMPUR, Malaysia, Jan. 27, 2025 /PRNewswire/ -- Hypertension, or high blood pressure, affects 3 in 10 Malaysians, making it a prevalent health concern in the country (National Health and Morbidity Survey, 2019). Of the 3, only 2 are awa...

2025-01-27 08:00 5664

FDA Clears World's First Mobile App for Contactless Pulse Rate Measurement

* PanopticAI's tech turns smartphones and tablets into medical-grade vital sign monitors. * This is a major milestone in the Hong Kong-based startup's mission to ensure accessible, scalable healthcare. * The AI-based technology's diverse use cases include telehealth, remote patient monitori...

2025-01-26 10:00 9277

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 25, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infectio...

2025-01-25 02:00 6876

Winter Davos 2025: Yidu Tech Accelerates Global Expansion of AI-Powered Healthcare Solutions

DAVOS, Switzerland, Jan. 24, 2025 /PRNewswire/ -- From January 20 to 24, the World Economic Forum Annual Meeting 2025, also known asWinter Davos, gathered global leaders inDavos, Switzerland. Representing China's AI-powered healthcare sector, Ms. Gong Rujing(Yingying), Founder and Chairwoman of Y...

2025-01-24 21:47 7460

Sino Group and the Ng Teng Fong Charitable Foundation Launch 'Community Care Chinese Medicine Service' with Hong Kong Baptist University to Support the Well-Being of the Underprivileged

HONG KONG, Jan. 24, 2025 /PRNewswire/ -- Sino Group (the 'Group'), the Ng Teng Fong Charitable Foundation ('NTFCF'), and the School of Chinese Medicine at Hong KongBaptist University ('HKBU') are committed to the well-being of underprivileged members of the community and have recently launched th...

2025-01-24 21:27 10443

Professor Tinly Wong Tin-Chee Pre- and Post-Exercise Care Tips from a Traditional Chinese Medicine Perspective

HONG KONG, Jan. 24, 2025 /PRNewswire/ -- The annual Hong Kong Marathon is just around the corner, and runners are actively preparing. In addition to physical training, proper warm-ups before the race and recovery after are equally important. Professor Tinly Wong Tin-Chee, founder of Herbalgy Phar...

2025-01-24 18:00 4792

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

MADISON, Wis., Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo® C Radiation Treatment Delivery System, a product built inChina th...

2025-01-23 20:35 4585

European Wellness Biomedical Group (EWBG) Partners with Toviyah Life to Unveil Cutting-Edge Health Technology

KOTA KINABALU, Malaysia, Jan. 23, 2025 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG) and Toviyah Life Pte Ltd (Toviyah) have announced a new partnership aimed at improving wellness through a handheld device called BeLight. The two companies signed a Memorandum of Understanding (MO...

2025-01-23 16:45 7549

Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

CHENGDU, China, Jan. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization inChina from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed innovativ...

2025-01-23 13:44 4072
1 ... 122123124125126127128 ... 381